Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Macimorelin stimulation test in healthy volunteers
NCT03844217Phase 1Completed
- Sponsor
- University Hospital Basel
- Start
- Mar 2019
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of macimorelin in Polyuria-polydipsia syndrome (PPS), sponsored by University Hospital Basel. Primary endpoint: Change in Copeptin value. Started Mar 2019; status: completed.
02
Drugs
macimorelin
03
Conditions
Polyuria-polydipsia syndrome (PPS)
Beyond the preview
Go deeper on NCT03844217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03844217.